世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

HSV Testing Market Size, Share & Trends Analysis By Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), By Test Type (Serological Tests, Point Of Care Tests), By Sample Type (Blood, Swabs, Cerebrospinal Fluid), By End-use, By Region, And Segment Forecasts, 2025 - 2033

HSV Testing Market Size, Share & Trends Analysis By Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), By Test Type (Serological Tests, Point Of Care Tests), By Sample Type (Blood, Swabs, Cerebrospinal Fluid), By End-use, By Region, And Segment Forecasts, 2025 - 2033


HSV Testing Market Summary The global HSV testing market size was estimated at USD 611.97 million in 2024 and is expected to reach USD 1017.75 million by 2033, growing at a CAGR of 5.96% from 2... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Grand View Research
グランドビューリサーチ
2025年7月28日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
電子ファイル - ご注文後3営業日前後 150 英語

 

Summary

HSV Testing Market Summary

The global HSV testing market size was estimated at USD 611.97 million in 2024 and is expected to reach USD 1017.75 million by 2033, growing at a CAGR of 5.96% from 2025 to 2033. This market encompasses diagnostic solutions aimed at the timely and reliable detection of herpes simplex virus types 1 and 2.

Testing platforms in this space range from traditional serological methods to advanced molecular assays, supporting clinical decisions across diverse healthcare environments. These solutions are primarily utilized in managing sexually transmitted infections and prenatal screening, with growing adoption in decentralized and point-of-care settings. The rising incidence of herpes simplex virus infections, along with heightened public awareness and efforts to improve sexual health screening, is supporting market expansion. Integration of HSV testing with digital platforms and remote diagnostic tools is further expanding access to care, particularly in low-resource and underserved settings, enabling earlier detection and timely clinical intervention.

Ongoing advancements in molecular diagnostic technologies are enhancing the sensitivity and turnaround time of HSV testing. Multiplex PCR platforms capable of detecting HSV alongside other sexually transmitted pathogens are gaining clinical preference, particularly in outpatient and emergency care settings. In addition, regulatory approvals for newer test kits with improved sample-to-answer workflows support their use in primary and urgent care environments.

Increased government initiatives and funding for STI surveillance and prevention programs also contribute to market growth. Public health campaigns, especially those targeting adolescent and reproductive health, are driving demand for accessible and accurate HSV testing. Collaborations between public health agencies and private diagnostic providers enable broader test availability, helping reduce diagnostic gaps in developed and resource-limited regions.

Global HSV Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global HSV testing market based on type, test type, sample type, end-use, and region:

• Type Outlook (USD Million, 2021 - 2033)
• HSV-1/HSV-2 Combines
• HSV-1
• HSV-2
• Test Type Outlook (USD Million, 2021 - 2033)
• Serological tests
• Direct detection tests
o PCR
o Viral culture
• Point-of-care tests
• Sample Type Outlook (USD Million, 2021 - 2033)
• Blood
• Swabs
• Cerebrospinal fluid
• End-use Outlook (USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Laboratories
• Clinics and Sexual Health Centers
• Home care / Self-testing
• Regional Outlook (USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. HSV Testing Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type Segment
1.1.1.2. Test Type Segment
1.1.1.3. Sample Type segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. HSV Testing Market: Executive Summary
2.1. Market Snapshot
2.2. Type and Test Type Snapshot
2.3. Sample Type Snapshot
2.4. End Use Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. HSV Testing Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising prevalence of HSV infections worldwide
3.4.2. Advancements in molecular and point-of-care Testing technologies
3.4.3. Public health initiatives and routine STI screening programs
3.5. Market Restraint Analysis
3.5.1. Limited diagnostic accuracy of serological tests
3.5.2. Stigma and underreporting associated with HSV infections
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. HSV Testing Market: Type Estimates & Trend Analysis
4.1. HSV Testing Market: Type Movement Analysis
4.2. HSV-1/HSV-2 Combines
4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. HSV-1
4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. HSV-2
4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. HSV Testing Market: Test Type Estimates & Trend Analysis
5.1. HSV Testing Market: Test Type Movement Analysis
5.2. Serological tests
5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Direct detection tests
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2. PCR
5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3. Viral culture
5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Point-of-care tests
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. HSV Testing Market: Sample Type Estimates & Trend Analysis
6.1. HSV Testing Market: Sample Type Movement Analysis
6.2. Blood
6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Swabs
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Cerebrospinal fluid
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. HSV Testing Market: End Use Estimates & Trend Analysis
7.1. HSV Testing Market: End Use Movement Analysis
7.2. Hospitals
7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Diagnostic Laboratories
7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Clinics and sexual health centers
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Home care / self-testing
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. HSV Testing Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America HSV Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. HSV Testing Market, 2021 - 2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada HSV Testing Market, 2021 - 2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico HSV Testing Market, 2021 - 2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Reimbursement Scenario
8.2.4.5. Competitive Scenario
8.3. Europe
8.3.1. Europe HSV Testing Market, 2021 - 2033 (USD Million)
8.3.2. UK
8.3.2.1. UK HSV Testing Market, 2021 - 2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. Germany
8.3.3.1. Germany HSV Testing Market, 2021 - 2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. Spain
8.3.4.1. Spain HSV Testing Market, 2021 - 2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. France
8.3.5.1. France HSV Testing Market, 2021 - 2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. Italy
8.3.6.1. Italy HSV Testing Market, 2021 - 2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark HSV Testing Market, 2021 - 2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden HSV Testing Market, 2021 - 2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway HSV Testing Market, 2021 - 2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia-Pacific HSV Testing Market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan HSV Testing Market, 2021 - 2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. China
8.4.3.1. China HSV Testing Market, 2021 - 2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. India
8.4.4.1. India HSV Testing Market, 2021 - 2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea HSV Testing Market, 2021 - 2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. Thailand
8.4.6.1. Thailand HSV Testing Market, 2021 - 2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. Australia
8.4.7.1. Australia HSV Testing Market, 2021 - 2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America HSV Testing Market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil HSV Testing Market, 2021 - 2033 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. Argentina
8.5.3.1. Argentina HSV Testing Market, 2021 - 2033 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.6. MEA
8.6.1. MEA HSV Testing Market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa HSV Testing Market, 2021 - 2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia HSV Testing Market, 2021 - 2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE HSV Testing Market, 2021 - 2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait HSV Testing Market, 2021 - 2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. NEW PRODUCT LAUNCH
9.2.2. PARTNERSHIPS
9.2.3. ACQUISITION
9.2.4. COLLABORATION
9.2.5. FUNDING
9.3. Key Company Market Share Analysis, 2024
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. F. Hoffmann-La Roche Ltd.
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Abbott
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Thermo Fisher Scientific Inc.
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. BD
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Bio-Rad Laboratories, Inc.
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. BIOMÉRIEUX
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. DiaSorin S.p.A.
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Hologic, Inc.
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Cepheid
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. QuidelOrtho Corporation
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives



Copy HTML

Content under List of Tables:
List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global HSV Testing Market, By Region, 2021 - 2033 (USD Million)
Table 4 Global HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
Table 5 Global HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 6 Global HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 7 Global HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 8 North America HSV Testing Market, By Country, 2021 - 2033 (USD Million)
Table 9 North America HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
Table 10 North America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 11 North America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 12 North America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 13 U.S. HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 14 U.S. HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 15 U.S. HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 16 U.S. HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Canada HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
Table 18 Canada HSV Testing Market, by Type, 2021 - 2033 (USD Million)
Table 19 Canada HSV Testing Market, by Test Type, 2021 - 2033 (USD Million)
Table 20 Canada HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 21 Mexico HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 22 Mexico HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 23 Mexico HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 24 Mexico HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Europe HSV Testing Market, by country, 2021 - 2033 (USD Million)
Table 26 Europe HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 27 Europe HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 28 Europe HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 29 Europe HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 30 UK HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 31 UK HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 32 UK HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 33 UK HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 34 Germany HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 35 Germany HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 36 Germany HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 37 Germany HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 38 France HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 39 France HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 40 France HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 41 France HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Italy HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 43 Italy HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 44 Italy HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 45 Italy HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Spain HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 47 Spain HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 48 Spain HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 49 Spain HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 50 Sweden HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 51 Sweden HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 52 Sweden HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 53 Sweden HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Norway HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 55 Norway HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 56 Norway HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 57 Norway HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 58 Denmark HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 59 Denmark HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 60 Denmark HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 61 Denmark HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific HSV Testing Market, by country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 64 Asia Pacific HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 65 Asia Pacific HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 66 Asia Pacific HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 67 Japan HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 68 Japan HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 69 Japan HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 70 Japan HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 71 China HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 72 China HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 73 China HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 74 China HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 75 India HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 76 India HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 77 India HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 78 India HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 79 Australia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 80 Australia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 81 Australia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 82 Australia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 83 Thailand HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 84 Thailand HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 85 Thailand HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 86 Thailand HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 87 South Korea HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 88 South Korea HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 89 South Korea HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 90 South Korea HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 91 Latin America HSV Testing Market, by country, 2021 - 2033 (USD Million)
Table 92 Latin America HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 93 Latin America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 94 Latin America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 95 Latin America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 96 Brazil HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 97 Brazil HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 98 Brazil HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 99 Brazil HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 100 Argentina HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 101 Argentina HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 102 Argentina HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 103 Argentina HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 104 MEA HSV Testing Market, by country, 2021 - 2033 (USD Million)
Table 105 MEA HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 106 MEA HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 107 MEA HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 108 MEA HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 109 South Africa HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 110 South Africa HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 111 South Africa HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 112 South Africa HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 117 UAE HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
Table 118 UAE HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 119 UAE HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 120 UAE HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait HSV Testing Market, by Sample Type, 2021 - 2033 (USD)
Table 122 Kuwait HSV Testing Market, By Type, 2021 - 2033 (USD Million)
Table 123 Kuwait HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 124 Kuwait HSV Testing Market, By End Use, 32021 - 2033 (USD Million)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Grand View Research社の 臨床検査分野 での最新刊レポート

本レポートと同じKEY WORD(sample)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/08/25 10:27

148.45 円

173.94 円

202.98 円

ページTOPに戻る